NEW YORK (GenomeWeb News) – The National Heart, Lung, and Blood Institute sees rapid point-of-care devices as offering great potential to help advance personalized medicine, and it plans to fund several research projects starting next year to spur development of these tools.

NHLBI specifically wants to provide funding to small businesses and research institutes seeking to develop POC technologies for use in diagnosing and guiding treatment of heart, lung, blood, and sleep disorders.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nature this week: genomic analysis of high-grade serous ovarian cancer, and more.

The new Riken president outlines some of his plans for the institute.

The Guardian discusses whether big science projects are worth the loss of resources available for other scientific pursuits.

An NEJM update from the ClinVar team highlights the difficulties of interpreting genetic variants.